Atlas Trials

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Clinical trial NCT02757391 · TERMINATED

Trial details

NCT number
NCT02757391
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Colorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal CarcinomaMetastatic Digestive System CarcinomaMetastatic Esophageal CarcinomaMetastatic Gastric CarcinomaMetastatic Pancreatic AdenocarcinomaStage IV Colorectal Cancer AJCC v7Stage IV Esophageal Cancer AJCC v7Stage IV Gastric Cancer AJCC v7Stage IV Pancreatic Cancer AJCC v6 and v7Stage IVA Colorectal Cancer AJCC v7
Start date
2019-08-09
Primary completion
2020-10-02
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.